IP Library Granted Patent US 12661444
Granted Patent B2
US 12661444 · App. 17/796,006 · Granted Jun 23, 2026

Drug container systems including lock-out mechanisms

Inventor: Jaime Ray Arnett (Fishers, IN)
Assignee: Eli Lilly and Company
A61M5/002A61M5/50
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12661444
App. No.
17/796,006
Granted
Jun 23, 2026
Kind
B2
Abstract

A drug delivery system includes a drug delivery device that carries and delivers a drug. The system further includes a housing, and the housing includes a main body and a cover coupled to the main body. The main body includes a chamber that carries the drug delivery device and an opening coupled to the chamber. The cover is movable relative to the main body from a closed position to an open position. In the closed position the cover obscures the opening and thereby inhibits egress of the drug delivery device from the chamber via the opening, and in the open position the cover permits egress of the drug delivery device from the chamber via the opening. A lock-out mechanism is carried by the housing. The lock-out mechanism inhibits the cover from returning to the closed position after moving to the open position.

Claims (23)

1 . A drug delivery system, comprising:

a drug delivery device carrying and configured to deliver a drug;

a housing, comprising:

a main body comprising a chamber carrying the drug delivery device and an opening coupled to the chamber;

a cover hingedly coupled to the main body, the cover being movable relative to the main body from a closed position to an open position, in the closed position the cover obscuring the opening and thereby inhibiting egress of the drug delivery device from the chamber via the opening, and in the open position the cover permitting egress of the drug delivery device from the chamber via the opening; and

a lock-out mechanism carried by the housing, the lock-out mechanism being movable from an initial position to a lock-out position, the lock-out mechanism occupying the initial position when the cover occupies the closed position, the lock-out mechanism occupying the lock-out position when the cover occupies the open position, and in the lock-out position the lock-out mechanism causing one of the drug delivery device and the lock-out mechanism to be disposed outwardly of the housing and thereby inhibit the cover from returning to the closed position.

2 . The drug delivery system of claim 1 , wherein the lock-out mechanism extends through the opening in the lock-out position.

3 . The drug delivery system of claim 1 , wherein the chamber is a main chamber and the opening is a main opening, the cover comprises a cover chamber carrying the lock-out mechanism and a cover opening coupled to the cover chamber, and wherein the lock-out mechanism extends through the cover opening in the lock-out position.

4 . The drug delivery system of claim 1 , wherein the lock-out mechanism is carried within the chamber.

5 . The drug delivery system of claim 1 , wherein the chamber is a main chamber, and wherein the cover comprises a cover chamber, the lock-out mechanism being carried within the cover chamber.

6 . The drug delivery system of claim 1 , wherein the lock-out mechanism comprises a resilient member configured to interfere with the cover to inhibit the cover from returning to the closed position after moving to the open position.

7 . The drug delivery system of claim 1 , wherein the lock-out mechanism comprises a resilient member configured to interfere with the main body to inhibit the cover from returning to the closed position after moving to the open position.

8 . The drug delivery system of claim 1 , wherein the drug delivery device is movable relative to main body from a storage position to a deployed position, in the closed position the cover holding the drug delivery device in the storage position, and in the open position the cover permitting the lock-out mechanism to urge the drug delivery device to the deployed position.

9 . The drug delivery system of claim 8 , wherein the lock-out mechanism is configured to inhibit the drug delivery device from returning to the storage position after moving to the deployed position and thereby inhibit the cover from returning to the closed position after moving to the open position.

10 . The drug delivery system of claim 8 , wherein the lock-out mechanism comprises:

a shuttle carrying the drug delivery device;

a shuttle holder translatably carrying the shuttle; and

a resilient member coupling the shuttle and the shuttle holder, the resilient member urging the shuttle and the drug delivery device away from the storage position and toward the deployed position.

11 . The drug delivery system of claim 10 , wherein at least one of: (i) the lock-out mechanism further comprises a pin-and-slot connection, the pin-and-slot connection coupling the shuttle to the shuttle holder and configured to inhibit the drug delivery device from returning to the storage position after moving to the deployed position, and the pin-and-slot connection thereby configured to inhibit the cover from returning to the closed position after moving to the open position; or (ii) the system further comprises an annular desiccant element configured to receive a portion of the drug delivery device and the shuttle holder, wherein said portion of the drug delivery device and the shuttle holder are in a coaxial relationship and the shuttle holder is at least one of rotationally and axially locked relative to the annular desiccant.

12 . The drug delivery system of claim 1 , wherein the lock-out mechanism comprises a resilient member, in the lock-out position the resilient member being disposed outwardly of the housing and thereby inhibiting the cover from returning to the closed position.

13 . The drug delivery system of claim 12 , wherein the resilient member is loaded in the initial position and unloaded in the lock-out position.

14 . The drug delivery system of claim 1 , wherein in the lock-out position the drug delivery device extends through the opening and thereby inhibits the cover from returning to the closed position.

15 . The drug delivery system of claim 14 , wherein the lock-out mechanism comprises a resilient member, the resilient member being loaded in the initial position and unloaded in the lock-out position, and in the lock-out position the resilient member urging the drug delivery device to extend through the opening and thereby inhibiting the cover from returning to the closed position.